Introduction. Given the unknown biologic antecedents before aortic aneurysm rupture, the purpose of this study was to establish a reproducible model of aortic aneurysm rupture. Methods. We fed 7-week-old apolipoprotein E deficient mice a high-fat diet for 4 weeks and osmotic infusion pumps containing Angiotensin II were implanted. Angiotensin II was delivered continuously for 4 weeks at either 1,000 ng/kg/min (n = 25) or 2,000 ng/kg/min (n = 29). A third group (n = 14) were given Angiotensin II at 2,000 ng/kg/min and 0.2% β-aminopropionitrile dissolved in drinking water. Surviving mice were killed 28 days after pump placement, aortic diameters were measured, and molecular analyses were performed. Results. Survival at 28 days was significantly different among groups with 80% survival in the 1,000 ng/ kg/min group, 52% in the 2,000 ng/kg/min group, and only 14% in the Angiotensin II/β-aminopropionitrile group (P = .0001). Concordantly, rupture rates were statistically different among groups (8% versus 38% versus 79%, P < .0001). Rates of abdominal aortic aneurysm were 48%, 55%, and 93%, respectively, with statistically higher rates in the Angiotensin II/β-aminopropionitrile group compared with both the 1,000 ng and 2,000 ng Angiotensin II groups (P = .006 and P = .0165, respectively). Rates of thoracic aortic aneurysm formation were 12%, 52%, and 79% in the 3 groups with a statistically higher rate in the Angiotensin II/β-aminopropionitrile group compared with 1,000 ng group (P < .0001). Conclusions. A reproducible model of aortic aneurysm rupture was developed with a high incidence of abdominal and thoracic aortic aneurysm. This model should enable further studies investigating the pathogenesis of aortic rupture, as well as allow for targeted strategies to prevent human aortic aneurysm rupture.
Introduction
After atherosclerosis, aneurysm is the most common disease of the aorta with aneurysm prevalence increasing with age. The Centers for Disease Control list abdominal aortic aneurysm (AAA) as the 15th leading cause of death in adults 60-64 years of age. 1 The most dreaded complication of AAA is aortic rupture, which occurs in an estimated 12,000-15,000 patients per year in the United States and has an associated mortality rate of 50%-80%. 2 These numbers may underestimate the true incidence rate, however, as patients with AAA are often asymptomatic, where rupture and death would occur before ever arriving at a hospital.
The study of aneurysm rupture in humans is limited because human aortic tissue is usually only obtained for research during surgical repair. This limits insight into the mechanisms leading to the initial development of an aneurysm, its gradual expansion, or its eventual rupture. Researchers therefore rely on animal models of aneurysm to better investigate these events, although these models may not perfectly recapitulate the biology of human aneurysm formation. Aortic rupture is a devastating result of aortic aneurysmal disease, but no known biologic markers of impending rupture allow physicians to predict which patients are at greatest risk of this catastrophic event. Additionally, few established, reproducible animal models of aortic rupture exist that would allow further investigation into the pathogenesis of rupture.
In contrast, many animal models are used to study the pathogenesis of AAA that typically do not result in rupture. These models include the use of genetically engineered mice with defects in aortic wall structure or aberrant cholesterol homeostasis. 3 Chemically induced AAA models are also well described in the literature and include utilization of periaortic or perfused elastase, periaortic calcium chloride, or subcutaneous Angiotensin II (AngII) infusion. 4, 5 Funded by the National Institutes of Health under Award Numbers T32HL007849, R01 HL132395, and R01 HL081629.
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Infusion of AngII at 1,000 ng/kg/min into apolipoprotein E deficient (ApoE −/−) mice has previously been shown to cause suprarenal AAAs and ascending thoracic aortic aneurysms (TAAs) that are independent of the AngII-induced elevated blood pressure. [6] [7] [8] [9] Highfat diets are used to further exaggerate the hyperlipidemic state in these knockout mice, resulting in greater atherosclerotic changes and aneurysm formation.
3 AAAs in this model are believed to have accelerated inflammation with resultant macrophage infiltration and associated elastin degradation. In addition to significant atherosclerosis and thrombus formation, many mice also develop associated focal dissections. 3, 8, 10 Although much research has been done to investigate the pathogenesis and treatment of AAAs, little investigation has been done to elucidate the biologic antecedents before rupture. We therefore aimed to develop a novel, reproducible model of aortic aneurysm rupture to better understand the events causing aneurysms to progress to rupture.
Materials and Methods

Angiotensin II infusion
We used 7-week-old ApoE −/− male mice (Jackson Laboratory, Bar Harbor, ME) that were housed and maintained at 70°F, 50% humidity, in 12-hour light-dark cycles per institutional animal protocols. All mice were fed ad libitum water and placed on a high-fat diet (TD 09682, Harlan Teklad Inc, Indianapolis, IN) with no restrictions on movement. Osmotic pumps (Alzet 1004, Durect Corp, Cupertino, CA) containing AngII (Sigma Aldrich Inc, St. Louis, MO) were then implanted into 3 groups of 11-week-old mice as previously described. 6, 11, 12 AngII was delivered at 1,000 ng/kg/min (n = 25) or 2,000 ng/kg/min (n = 29). A third group (n = 14) was given 0.2% β-aminopropionitrile (BAPN) (Sigma Aldrich) dissolved in drinking water 3 days before osmotic pump placement. These mice also received AngII at a rate of 2,000 ng/kg/min and were continuously given BAPN until the end of the experiment. Any mouse that died before the study endpoint underwent autopsy to determine cause of death. After 28 days, surviving mice were killed under anesthesia by overdose and exsanguination. The aorta was dissected free from surrounding tissue and fully visualized (ascending to iliac bifurcation) for video micrometry measurements of the aortic diameter using NIS-Elements D.3.10 software attached to the microscope (Nikon SMX-800, Melville, NY). Suprarenal aortic samples were then collected, flash frozen, and stored at −80°C or embedded in paraffin for histology.
The experiment was repeated except with killing 4 days after osmotic pump placement because a large proportion of mice in the AngII/BAPN group did not survive for the full 28 days. Day 4 was chosen as an end point because prior aneurysm experiments in our laboratory have shown peak infiltration of neutrophils and macrophages occurs at 3-7 days. 4 These day-4 mice (n = 15/group) were cared for and harvested in the same manner as described in the previous paragraph.
Animal care and use were in accordance with the Guide for the Care and Use of Laboratory Animals. The animal protocol was approved by the University of Virginia Institutional Animal Care and Use Committee (#3848) in compliance with the Office of Laboratory Animal Welfare.
Histology
Murine aortas (n = 7-9/group) were killed on day 4 for histology analysis after undergoing left ventricular puncture and 4% paraformaldehyde (PFA) antegrade perfusion at physiologic pressure. Further fixation was achieved by overnight incubation in 4% PFA at 4°C followed by paraffin embedding and sectioning at 5 μm.
After microwave antigen retrieval, antibodies were bound and detected using VectaStain Elite Kit (Vector Laboratories Inc, Burlingame, CA). Antibodies for IHC staining were anti-mouse anti-Neutrophil (Ly 6B.2) for neutrophils (1:10,000; AbD Serotec, Oxford, United Kingdom), anti-rat Mac2 for macrophages (1:10,000; Cedarlane Laboratories, Burlington, Canada), CD3 for T-cells (1:100; Santa Cruz Biotechnology Inc, Santa Cruz, CA), anti-mouse SMαA for smooth muscle α-actin (1:1000; Santa Cruz Biotechnology Inc., Santa Cruz, California), Verhoeff Van Gieson for elastin, as previously described. 5 Visualization of color development was completed using diaminobenzidine (Dako Corporation, Carpinteria, CA) for SMαA, Mac2, anti-neutrophil and CD3. Images were acquired using AxioCam Software v 4.6 via 10×, 40×, and 100× objectives and an AxioCam MRc camera (Carl Zeiss Inc, Thornwood, NY). Slides were then graded by 3 blinded reviewers using the following scales:
Elastin: (1) no degradation, (2) 
Protein extraction
Protein was extracted from frozen aortic tissue samples with phosphate buffer saline (PBS) and protease inhibitors (Roche Diagnostics, Indianapolis, IN) as previously described.
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Cytokine array
For the purpose of determining the effects of AngII and BAPN on pro-inflammatory cytokines in the aortic wall, mouse cytokine arrays (R&D Systems, Minneapolis, MN) were performed using isolated protein from mouse aortas at day 4 or 28, according to the manufacturer's instructions (n = 3-5/group at 4 days and n = 2/ group at 28 days). Protein samples from each group were pooled for analysis and all samples were run in duplicate. 13 Given the high rate of rupture in the AngII/BAPN group at 28 days and the fact that aortic protein samples were pooled, these results were not statistically compared.
Zymography
Using protein isolated from the aortic samples, gelatin zymography was performed to determine matrix metalloproteinase (MMP) 2 and 9 activity. Individual mouse aortas (n = 2/group at 28 days and n = 3-5/group at 4 days) were used. Precast zymography gels (10%, Invitrogen, Carlsbad, CA) were loaded with 3 μg of tissue protein from each aortic sample. Samples were diluted into 2× Trisglycine SDS sample buffer and electrophoretically separated under nonreducing conditions. The gels were renatured for 30 minutes in renaturing buffer (Invitrogen, Carlsbad, CA) and incubated in developing buffer for 24 hours at 37°C rocker. The gels were then stained in Simply Blue Safe Stain (Invitrogen). Pro-and active forms of MMP2 and 9 appeared as a clear band against the blue background. Quantification was determined according the optical density using Bio-Rad Image Lab Software v 4.0 (Bio-Rad, Hercules, CA).
Statistical methods
Statistical analysis was performed using GraphPad Prism 7 software (GraphPad Software, La Jolla, CA). Categorical data were assessed using a χ 2 test. Kaplan-Meier survival curves tracked the percentage survival of mice during the 28-day period and were assessed by log-rank (Mantel-Cox) test. Differences between groups for histologic grading for elastin degradation, SMC loss and macrophage, T cell and neutrophil infiltration were tested with a 1-way ANOVA with Tukey correction for multiple comparisons. Blinding to experimental groups was maintained for histologic grading.
Results
AngII and BAPN increase aneurysm formation
Exposure to continuous AngII with or without BAPN resulted in aneurysm formation in mice in all groups in both the suprarenal abdominal aorta and the ascending thoracic aorta. The incidence of AAA was higher in the AngII/BAPN group than in both the 1,000-ng (93% versus 48%; P = .006) and 2,000-ng (93% versus 55%; P = .0165) groups (Fig 1, A) . The rate of TAA was statistically higher in the AngII/BAPN group than in the 1,000-ng group (79% versus 12%; P < .0001), although not statistically different from the 2,000-ng group (79% versus 52%; P = 0.1107) (Fig 1, B) . The incidence of TAA in the 2,000-ng group was significantly higher than the 1,000-ng group (52% versus 12%; P = .0033).
Survival decreases with increasing AngII and addition of BAPN. The survival rate was significantly different among the 3 groups of mice with 80% survival in the 1,000-ng group, 52% in the 2,000-ng group and only 14% in the AngII/BAPN group (P = .0001; Fig 2) . Unadjusted comparisons between each group were also significantly different (all P < .05). Although most early deaths were secondary to aortic rupture, there were mice (3 [12%] in 1,000-ng, 3 [10%] in Fig. 1 . Increased aneurysm incidence in AngII/BAPN group. (A) Abdominal aortic aneurysm (AAA) incidence. AAA was more common in the AngII/BAPN group than in both the 1,000-ng (93% versus 48%, P = .006) and 2,000-ng (93% versus 55%, P = .0165) groups. (B) Thoracic aortic aneurysm (TAA) incidence. TAA incidence was higher in the AngII/BAPN group than the 1,000-ng (79% versus 12%, P < .0001) and the 2,000-ng groups (79% versus 52%, P > .05) groups. The 2,000-ng group also had more TAAs than the 1,000-ng group (52% versus 12%, P = .0033).
Fig. 2.
Decreased survival in AngII/BAPN group. With increasing AngII dosing and the addition of BAPN, survival at 28 days decreased from 80% survival in the 1,000-ng group to 52% in the 2,000-ng group and 14% in the AngII/BAPN group (P = .0001).
2,000-ng and 1 [7%] in AngII/BAPN groups) that died from unknown causes when examined during autopsy.
The rate of aortic rupture increased with higher AngII dosing and the addition of BAPN. The incidence of rupture in each group was 8%, 38%, and 79% in 1,000-ng, 2,000-ng, and AngII/BAPN groups, respectively (P < .0001) (Fig 3) . Unadjusted comparisons between each group were significantly different (all P < .05). The location of rupture was TAA in all the 1,000-ng mice that died from rupture. In the 2,000-ng group, 55% had ruptured TAA, 27% had ruptured AAA, and 18% ruptured in both TAA and AAA locations. Finally, in the AngII/ BAPN group, 27% had ruptured TAA, 45% had ruptured AAA, and 27% ruptured in both TAA and AAA locations.
Histologic differences are not appreciated early in rupture model
Histologic analysis of aortas from mice killed after 4 days showed no statistical differences (all P > .05) in degree of elastin degradation, smooth muscle cell loss or neutrophil, macrophage or T-cell infiltration. However, the trend was toward more neutrophil (1.1-point increase) and macrophage (1.0-point increase on grading scale) infiltration in the aortas of mice in the AngII/BAPN group compared with those in the 2,000-ng group. Comparison suffered from not enough mice surviving to day 28 to allow histologic analysis.
Exposure to increasing AngII and BAPN upregulates inflammatory cytokines
In pooled aortic samples from mice that survived to day 28, most inflammatory cytokines were upregulated in the AngII/BAPN group when compared with both the 1,000-ng and 2,000-ng groups. The Table shows fold increases in cytokines in the AngII/BAPN group compared with the 2,000-ng group alone; similar changes were seen when compared with the 1,000-ng group. At day 4, however, only IL-1β, Il-1RA, CXCL1, MCP-1, MIP-2, CCL17, and TREM-1 were more elevated in the AngII/BAPN group (Fig 4, A) . These same cytokines are documented on day 28 in Fig 4, B. 
Increasing AngII and BAPN exposure upregulates matrix metalloproteinases
At 28 days, both pro-and active MMP9 and MMP2 were elevated in the AngII/BAPN group when compared with the other 2 groups (Fig 5) . There was a statistical difference in active MMP9 and active MMP2 when compared with both the 1,000-ng and 2,000-ng groups (all P < .01). In day 4 mice, pro-and active MMP9 were again highest in the AngII/BAPN group (P < .01, data not shown in separate figure).
Discussion
Using a combination of AngII and BAPN, these experiments have demonstrated a new model of aortic aneurysm rupture with nearly 80% of mice succumbing to aneurysm rupture by day 28. The mice in this group developed high rates of both AAA and TAA, thus allowing further investigation into the differential pathogenesis of aortic aneurysms and their rupture in both the abdominal and thoracic aorta.
The AngII model is a well-established and accepted model of AAA, despite some of the typical limitations of animal models of human disease. It mimics human aneurysm development because the model causes noted luminal dilation, degeneration of the media, and thrombosis of the aorta. 3 Additionally, the AngII mouse model is consistent with human disease where men have twice the rate of AAA as women. 14 The experiments in this study were therefore performed only in male mice to maximize aneurysm formation and subsequent rupture. In the present experiment, the standard dose of AngII was doubled in 2 of the 3 test groups to both increase the rate of AAA formation and to induce aneurysm ruptures. The addition of the irreversible lysyl oxidase inhibitor BAPN, which prevents elastin and collagen cross-linking in the elastic lamina, serves as another insult to aortic integrity in this rupture model. 15 The combination of AngII delivered at 1,000 ng/kg/min and BAPN has been described previously as a means for inducing aortic dissection. 16 In that study, 100% of mice developed an acute aortic dissection and 30% of mice died as a result of aortic rupture within 24 hours of AngII infusion. Although this rupture rate is far higher than in our 1,000-ng group, that study exposed mice to BAPN for 4 weeks before introduction of AngII, likely causing a greater extent of medial degeneration than in our model in which mice were started with BAPN only 3 days before AngII infusion. Other studies have used subcutaneous BAPN to induce aortic aneurysms and rupture in rats; however, these studies had high early rupture rates, likely secondary to acute inflammation. 17, 18 Our laboratory has recently published a study utilizing lower-dose BAPN dissolved in water (0.2%) to induce less acute aortic injury to develop a more chronic model of AAA. 4 We elected to use this lower dose again in our rupture model with a goal of having increased survival to the experiment endpoint.
In this study mice in the AngII/BAPN group developed more AAAs and TAAs than mice in either the 1,000-ng or 2,000-ng group. In Fig. 3 . Increased AAA and TAA rupture in AngII/BAPN group. With increasing AngII dosing and the addition of BAPN, rupture increased with 8% in the 1,000-ng group, 38% in the 2,000-ng group, and 79% in the BAPN group (P < .0001). initial studies using the AngII model, AAAs were noted in approximately one third of mice at doses of 1,000 ng/kg/min. 6 Our mice, which were given the same dose of AngII, developed AAAs at a rate of 48%. This difference may be attributable to the fact that they were also fed a high-fat, "Western" diet, which intensifies atherosclerotic changes in the aortas of these ApoE−/− mice. A recent metaanalysis of all studies using the AngII model, however, showed that AngII dose and diet type had only moderate, nonsignificant effects on the reported incidence of AAA. 19 The high incidence of ascending TAAs in our model will also allow further investigation into ascending aneurysms, particularly ruptured ascending aneurysms, in the future.
Mice in the AngII/BAPN group experienced rupture more commonly with decreased overall survival compared with the other 2 experimental groups. Although some mice in each group died without an obvious aneurysm or aortic rupture at autopsy, the AngII model in ApoE −/− mice is known to promote diffuse atherosclerosis, including coronary disease, and this serves as one possible explanation for cause of death in several of these animals. 20 BAPN has also been used in our laboratory in conjunction with periaortic elastase administration to establish a model of chronic, advancedstage AAA. 4 This 100-day model resulted in rupture in 46% of mice, with ruptures occurring either as early (~1 week after surgery) or late (60-80 days after surgery) events. Ruptures in our model using BAPN and AngII began as early as postoperative day 3 and continued until day 28. The higher rate of rupture throughout the entire experimental time is likely related to the more inflammatory nature of the AngII model in addition to the aortic dissections seen in this model.
In mice that survived to day 28, most inflammatory cytokines were upregulated in the AngII/BAPN group when compared with the 1,000-ng and 2,000-ng groups. These mice had the greatest insult to their aorta and therefore would be expected to have a more significant inflammatory response and greater influx of leukocytes. Because the aortas in each group were pooled to use the cytokine array kit, it was not possible to perform statistical analysis to test Fig. 4 . Increased inflammatory cytokines in AngII/BAPN group. All tested inflammatory cytokines appeared to be upregulated in the pooled aortas of mice in the AngII/ BAPN group when compared with the 1,000-ng and 2,000-ng groups at day 28. (A) In day 4 aortas only IL-1β, IL-1RA, CXCL1, MCP-1, MIP-2, CCL17, and TREM-1 were more elevated in the AngII/BAPN group than the other two groups. (B) In day 28 aortas these 7 cytokines were also elevated in the AngII/BAPN group when compared with the 1,000-ng and 2,000-ng groups.
for significance. We did note, however, that 7 cytokines were markedly elevated in the aortas of mice in the AngII/BAPN group by day 4, suggesting that these cytokines may be most important in the onset of aneurysm formation and progression. Further focus on these specific cytokines will need to be performed in future studies to describe more clearly their role in AAA and rupture pathology.
MMPs degrade elastin and collagen in the aortic media and several, including MMP2 and MMP9, have been implicated in the development of aortic aneurysms in both human and animal aneurysms. [21] [22] [23] AngII infusion is thought to further augment MMP production in mouse models of atherosclerosis and AAA formation. 7 In this study, pro-and active MMP2 and MMP9 were all elevated in the AngII/BAPN group when compared with the other 2 groups at 28 days. Likewise, on day 4, pro-and active MMP9 were again highest in the AngII/BAPN group. MMP2 and MMP9 have been demonstrated to peak at day 28 in prior AngII experiments in our laboratory. 24 Perhaps with the addition of BAPN, however, this rise in expression of MMP9 starts far earlier, potentially contributing to increased aneurysm and rupture rates in this group.
There are limitations to the present study including the continued need to better define specific targets affecting the biology of aneurysm rupture. Additionally, although most mice in the AngII/ BAPN group experienced the desired outcome of aortic rupture, the number of mice surviving to the study end was minimal, making intense investigation of the biologic mechanisms limited. In the future, the protocol will need to be modified to increase survival and our ability to study these mechanisms using physiologic monitoring before aortic rupture. Another limitation is that mice in the AngII model do not form aneurysms or develop ruptures at a uniform time or anatomic location; these events can happen as early as day 3 and as late as day 28. The addition of blood pressure monitoring may assist in detection of rupture before the animals' deaths, again, perhaps, allowing the identification of important biologic precursors.
In conclusion, this model of 2,000 ng/kg/min AngII plus 0.2% BAPN created a model with 79% aneurysm rupture in the abdominal or thoracic aorta. The high penetrance of both abdominal and thoracic aneurysms leading to aneurysm rupture makes it an ideal model for studying this pathology. This novel, reproducible model will allow for investigation into the antecedent events leading to rupture to identify targets that allow prediction or even prevention of rupture in mice and, hopefully, eventually, in humans. 5 . Increased MMP activity in AngII/BAPN group. In day 28 aortic samples pro-and active forms of MMP9 and 2 were increased in animals in the AngII/BAPN group compared with those in the 1,000-ng and 2,000-ng groups (white bands on blue background). *P < .01.
